The National Biosafety Authority (NBA) has approved two applications on HIV vaccine trials and Malaria control for the Centre for Infectious Disease Research in Zambia (CIDRZ) and Macha Research Trust respectively. The CIDRZ permit is for conducting research trials on the safety and immunogenicity of HVTN 120/ALVAC and will be conducted in Lusaka while the malaria control will be done at Macha Research Trust, Choma in Southern Province.


  • Press Statement – NBA Approves HIV Vaccine Trials and Malaria Control Research Projects